CYMEVENE

This brand name is authorized in Austria, Australia, Brazil, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CYMEVENE contains one active pharmaceutical ingredient (API):

1 Ganciclovir UNII 02L083W284 - GANCICLOVIR SODIUM

Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV). Read about Ganciclovir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CYMEVENE Powder for concentrate for solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AB06	Ganciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10328N, 5749N, 6136Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529201302152315
Country: EE	Ravimiamet	Identifier(s): 1022252, 1085228, 1825275, 1826276
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58266
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 169557
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 43515
Country: HK	Department of Health Drug Office	Identifier(s): 60055
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-230718931
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3472
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002130
Country: MT	Medicines Authority	Identifier(s): AA565/19902, AA729/00202
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 27065
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5931
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100016430, 100257865, 100296256, 100310708, 100347090, 100425736
Country: SG	Health Sciences Authority	Identifier(s): 05051P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680979254059
Country: ZA	Health Products Regulatory Authority	Identifier(s): Y/20.2.8/291